Omnes Capital

VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for semiconductor chips used in advanced digital communications systems, including 5G networks. Founded in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the need for DSP co-processors, allowing for greater flexibility akin to software programming. VSORA's innovative DSP development flow facilitates collaboration between signal processing and software engineers, significantly accelerating time-to-market for new products. The company focuses on enhancing DSP computing power while optimizing power consumption and performance, ultimately reducing the silicon footprint required for complex integrated circuits.

ARX is a defense technology company that specializes in the development of autonomous unmanned systems for dual-use applications.

Sekoia.io is a developer of an advanced security operations center (SOC) platform that equips security teams with tools to effectively identify and respond to significant cyber threats across their entire attack surface. The platform integrates real-time detection and automation, allowing teams to manage the complexities and high volumes of security incidents while reducing false positives. By continuously analyzing emerging threats and implementing strategic responses, Sekoia.io enables organizations to enhance their security posture and respond to threats more swiftly and reliably than traditional security information and event management (SIEM) systems. This proactive approach ensures that clients remain informed and prepared against evolving cyber risks.

Coave Therapeutics specializes in developing gene therapies for rare ocular and central nervous system (CNS) diseases. Their primary focus is creating treatments for rare retinal disorders using a recombinant adeno-associated virus vector, which delivers a functional copy of the PDE6B gene directly between photoreceptors and the retinal pigment epithelium to provide effective visual restoration.

Planet A Foods is a producer of plant-based, cocoa-free chocolate that focuses on creating food products from natural ingredients. The company emphasizes local production to minimize the impact on land and resources while aiming to reduce global carbon emissions. By utilizing traditional fermentation techniques, Planet A Foods offers an alternative to conventional chocolate, allowing consumers to enjoy chocolate flavors without the associated environmental drawbacks of unsustainable cocoa production.

The Exploration Company specializes in the development and operation of modular and reusable spacecraft, known as Nyx, designed for use in low Earth orbit and near the Moon. These spacecraft can be refueled in orbit and utilize environmentally friendly propellants, promoting sustainable space exploration. The company aims to democratize access to space by providing a cost-effective alternative for conducting in-space experiments, making it easier for new entrants to participate in the space exploration sector. Additionally, it offers an open-source operating system for its spacecraft, enhancing accessibility and innovation in the industry.

Qantev is an innovative company specializing in a health claims platform that leverages artificial intelligence to enhance insurer claims operations. The platform utilizes a proprietary algorithm designed to optimize the configuration of provider networks and identify suitable providers. By analyzing historical claims data, Qantev assists health insurers globally in reducing claims leakage, thereby enabling them to make informed, data-driven decisions. This capability empowers health insurance teams to develop effective business strategies and improve their overall operational efficiency.

Carbyon is a Netherlands-based company specializing in direct air capture (DAC) technologies aimed at reducing carbon dioxide (CO2) levels in the atmosphere. The company has developed innovative 'fast-swing' technology that effectively filters CO2 from ambient air and delivers it in a purified form for various applications, including the production of kerosene for aircraft. This approach allows for the repurposing of existing fossil fuel infrastructure to accommodate renewable hydrocarbons, thus facilitating a transition toward more sustainable energy sources. By enabling the use of alternative energy carriers such as batteries and hydrogen, Carbyon contributes to significant advancements in transportation systems, energy grids, and gas transportation networks.

Unseenlabs is a French company founded in 2015 and headquartered in Rennes, Brittany, specializing in marine surveillance services. The company designs and develops advanced spectrum surveillance payloads that enable the detection and tracking of non-cooperative vessels worldwide. Unseenlabs offers comprehensive solutions that encompass satellite design, deployment, and operational support. By launching satellites that can detect and geolocate signals and electromagnetic waves emitted by ships, Unseenlabs provides clients with the capability to monitor maritime activities, even when vessels disable their Automatic Identification System beacons. This technology is particularly valuable for identifying illegal operations such as fishing violations, degassing, and maritime piracy.

EEF Erneuerbare Energien Fabrik is a power generation company specializing in renewable energy. It develops, implements, and operates wind energy and photovoltaic projects, along with energy storage solutions, to facilitate the decarbonization of the energy market. The company also employs AI software to enhance its operations.

GEEV is a collaborative mobile application that facilitates the donation and collection of various items among its users, promoting a culture of sharing and reducing waste. The platform allows individuals to donate objects they no longer need and to retrieve free items from others in their community. By providing features for communication and coordination, GEEV fosters interaction between users, enabling them to discuss and arrange meetups for the exchange of goods. The app not only helps users declutter but also encourages sustainable practices by giving objects a second life, thereby contributing to waste reduction efforts.

Planet A Foods is a producer of plant-based, cocoa-free chocolate that focuses on creating food products from natural ingredients. The company emphasizes local production to minimize the impact on land and resources while aiming to reduce global carbon emissions. By utilizing traditional fermentation techniques, Planet A Foods offers an alternative to conventional chocolate, allowing consumers to enjoy chocolate flavors without the associated environmental drawbacks of unsustainable cocoa production.

Quandela is a company focused on advancing quantum computing technology, specifically in the realms of communication networks and optical computers. It specializes in manufacturing photonic quantum computers, which it supplies to industrial clients. A key innovation from Quandela is its single-photon source device, which integrates photonics with semiconductor quantum dots. This device enables the efficient collection of emitted single photons at high rates, significantly reducing charge noise decoherence and facilitating the emission of identical photons with high fidelity. Such capabilities are essential for the development of advanced quantum applications in communication, computation, and sensing, positioning Quandela as a pivotal player in the quantum technology landscape.

Quantum system develops manufactures and sells unmanned aerial systems, which provide aerial intelligence to commercial and governmental clients around the world.

Corteria Pharmaceuticals is a biotechnology company dedicated to developing innovative therapies for heart failure subpopulations, particularly focusing on acute decompensated heart failure. The company aims to address unmet medical needs by creating first-in-class drugs that enhance the understanding of disease biology among medical professionals. In addition to heart failure, Corteria also explores treatments for related conditions, such as sarcopenia and obesity, to improve patient outcomes and provide effective solutions for complex health issues. Through its research and development efforts, Corteria Pharmaceuticals seeks to transform the landscape of heart failure treatment.

PeopleSpheres is a Paris-based company that specializes in providing a comprehensive human resources information system (HRIS) software solution designed to meet the diverse needs of businesses. Founded in 2010 and originally named NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. The software solution offered by PeopleSpheres is tailored to be suitable, sustainable, and scalable, addressing the specific challenges faced by organizations in HR management. To enhance its offerings, PeopleSpheres collaborates with leading national HR service providers, particularly targeting American businesses. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS, further solidifying its position in the HR technology space.

Sekoia.io is a developer of an advanced security operations center (SOC) platform that equips security teams with tools to effectively identify and respond to significant cyber threats across their entire attack surface. The platform integrates real-time detection and automation, allowing teams to manage the complexities and high volumes of security incidents while reducing false positives. By continuously analyzing emerging threats and implementing strategic responses, Sekoia.io enables organizations to enhance their security posture and respond to threats more swiftly and reliably than traditional security information and event management (SIEM) systems. This proactive approach ensures that clients remain informed and prepared against evolving cyber risks.

DiogenX is a preclinical stage biotechnology company based in Marseille, France, with research facilities in Nice. Founded in 2019, it specializes in developing therapeutic solutions for diabetic patients, focusing on pancreatic beta-cell modulators for the treatment of both Type 1 and Type 2 diabetes. The company aims to create a candidate molecule that regenerates pancreatic insulin-producing cells, which could significantly improve the quality of life and survival rates for individuals with diabetes. This innovative approach has the potential to become a groundbreaking therapy for beta-cell regeneration in diabetes management, stemming from research conducted in the laboratory of Dr. Patrick Collombat.

Iktos is a French scale-up company focused on applying artificial intelligence and robotic technologies to medicinal chemistry and drug design. The company has developed a proprietary generative AI solution that optimizes small molecules in silico, enhancing productivity in pharmaceutical research and development. Iktos offers its expertise through its SaaS platforms, Makya™ for generative drug design and Spaya™ for retrosynthesis, while also collaborating with pharmaceutical companies to accelerate drug discovery processes. Additionally, Iktos has created Iktos Robotics, an AI-driven automation platform that significantly speeds up the Design-Make-Test-Analyze cycle in drug discovery. The company is also advancing its own pipeline of drug candidates aimed at oncology and autoimmune diseases. In 2023, Iktos completed a significant financing round and, in 2024, expanded its capabilities through the acquisition of Synsight, integrating a biology platform focused on discovering new drugs that target Protein-Protein Interactions and RNA-Protein Interactions.

The Exploration Company specializes in the development and operation of modular and reusable spacecraft, known as Nyx, designed for use in low Earth orbit and near the Moon. These spacecraft can be refueled in orbit and utilize environmentally friendly propellants, promoting sustainable space exploration. The company aims to democratize access to space by providing a cost-effective alternative for conducting in-space experiments, making it easier for new entrants to participate in the space exploration sector. Additionally, it offers an open-source operating system for its spacecraft, enhancing accessibility and innovation in the industry.

VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for semiconductor chips used in advanced digital communications systems, including 5G networks. Founded in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the need for DSP co-processors, allowing for greater flexibility akin to software programming. VSORA's innovative DSP development flow facilitates collaboration between signal processing and software engineers, significantly accelerating time-to-market for new products. The company focuses on enhancing DSP computing power while optimizing power consumption and performance, ultimately reducing the silicon footprint required for complex integrated circuits.

Opensee is a Paris-based fintech company that specializes in providing self-service analytics solutions for financial institutions. Founded by a team of experts from the financial and technology sectors, Opensee addresses the challenges posed by big data by enabling organizations to efficiently analyze vast quantities of data on demand. The platform allows business users to perform in-depth analyses and what-if scenarios, facilitating better decision-making in areas such as risk management in capital markets and resource management in commercial and retail banking. By transforming complex data into actionable insights, Opensee empowers financial institutions to enhance their market intelligence and streamline regulatory reporting processes.

Dust Mobile, established in 2017 and based in Brussels, Belgium, specializes in cybersecurity solutions for mobile networks. The company offers comprehensive protection against threats intrinsic to cellular mobile network signaling (2G, 3G, 4G LTE, and 5G) and SIM cards. Dust Mobile's services include secure voice, text, and data communication solutions, designed to safeguard businesses, critical operations, and connected devices globally.

Qantev is an innovative company specializing in a health claims platform that leverages artificial intelligence to enhance insurer claims operations. The platform utilizes a proprietary algorithm designed to optimize the configuration of provider networks and identify suitable providers. By analyzing historical claims data, Qantev assists health insurers globally in reducing claims leakage, thereby enabling them to make informed, data-driven decisions. This capability empowers health insurance teams to develop effective business strategies and improve their overall operational efficiency.

Gourmey is a pioneering cultivated meat company based in Paris, France, founded in 2019. It specializes in the development and production of ethical foie gras derived from duck cells, aiming to revolutionize the traditional foie gras industry. By utilizing a lab-based approach, Gourmey cultivates meat without the need for force-feeding or slaughter, ensuring a more humane and sustainable alternative. The company places duck cells in a controlled environment, providing optimal temperature, essential nutrients, and space for growth, which results in a product that prioritizes consumer health, environmental sustainability, and animal welfare.

Ternoa is a technology company based in Biarritz, Nouvelle-Aquitaine, France, specializing in blockchain solutions for secure and anonymous data transfer. Founded in 2013, Ternoa's innovative technology facilitates digital transmission, allowing users to safely store and manage encrypted data through decentralized storage providers. By employing multi-party cryptography, the company ensures the long-term integrity of data, particularly in the context of non-fungible tokens (NFTs). Ternoa's approach eliminates the need for intermediaries, enabling seamless and secure access to digital information for users worldwide.

WhiteLab Genomics specializes in the development of a proprietary platform that integrates graph knowledge technology and machine learning to advance genomic therapies. The company assists genomic medicine scientists in obtaining accurate and comprehensive insights into essential scientific and technological inquiries. This includes optimizing vector design, assessing genotoxicity, and establishing optimal experimental protocols for both in vivo and in vitro applications. WhiteLab Genomics supports clients throughout the in-silico development phase, facilitating the rapid development of target vectors and payloads, ultimately expediting the delivery of innovative genomic therapies to patients. By processing a wide array of scientific, technical, biological, and genomic datasets, the company enhances the efficiency of research and development in gene and cell therapies.

Qubit Pharmaceuticals is a Paris-based company established in 2020, focusing on innovative technology for pharmaceutical drug discovery. Founded by prominent academic institutions and researchers, including CNAM, CNRS, the University of Texas at Austin, Sorbonne University, and Washington University, the company leverages over 20 years of research and development. Qubit Pharmaceuticals has developed a drug discovery simulation platform that aims to significantly reduce the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, the platform facilitates virtual screening and visualization of potential drug candidates. By integrating principles of quantum physics, Qubit Pharmaceuticals supports biopharmaceutical companies in accelerating their research and development processes, ultimately enhancing the efficiency of drug discovery.

Therapixel SA is a company based in Valbonne, France, with additional locations across multiple countries, including Australia and China. Founded in 2013, Therapixel specializes in designing and developing medical image analytics software for surgeons, leveraging artificial intelligence to enhance surgical procedures. Their product portfolio includes Radvise, an automatic image reading solution; Fluid, a touchless medical image navigation system for surgery; Anywhere, a post-processing workstation; and CD-Feed, a solution for importing CDs from outpatient imaging exams. The company also focuses on AI-based software for breast cancer detection and characterization, providing healthcare professionals with pertinent information to support decision-making during surgeries while adhering to sterility constraints.

Domain Therapeutics SA is a biopharmaceutical company based in Illkirch-Graffenstaden, France, focused on the discovery and early development of therapeutic drugs targeting G protein-coupled receptors (GPCRs), which are key drug targets in various diseases. Founded in 2001, the company specializes in developing small molecules for the treatment of central nervous system (CNS) disorders and cancer. It employs its proprietary technology platform, DTect-All, which enables the identification of orthosteric and allosteric ligands, including Silent Allosteric Modulators (SAMs) that are challenging to discover using conventional methods. In addition, Domain Therapeutics offers BioSens-All, a platform to explore the signaling complexities associated with GPCR activation, enhancing its ability to address difficult targets, such as orphan and peptidic GPCRs.

TagEnergy is a clean energy enterprise for a new cycle in the renewable energy industry. It was formed in 2019 to accelerate the energy transition by developing and investing in competitive and clean power stations in order to compete directly and actively on the energy markets. Renewables have now become the main source of energy able to provide both social responsibility and price efficiency, and we are delivering this in the countries where we have established our activity. ​TagEnergy is operated by a highly-experienced team of manager-shareholders. Its operations span the renewables value chain, from development, financing, construction and asset management of wind, solar and storage projects, to commercialisation of its competitive energy. TagEnergy has developed a portfolio of 2.7GW in the UK, Australia, Spain, Portugal and France, and intends to drive the pace of transition through projects that deliver reliable energy affordably, and at scale.

Skillup is a provider of educational training and talent management software aimed at assisting companies in researching, comparing, and booking professional training courses. The platform hosts over 20,000 training programs and features more than 50,000 reviews, positioning itself as a comprehensive resource for HR services seeking suitable training for employees. Its software includes a reservation engine and various SaaS tools that optimize the management of training, interviews, and skills. By streamlining the construction and implementation of training plans, Skillup enables employers and HR managers to concentrate on strategic talent engagement, growth, and retention.

SeqOne S.A.S. is a company based in Montpellier, France, that specializes in developing genomic data analysis software for the healthcare industry. Founded in 2017, SeqOne's platform offers end-to-end management of next-generation sequencing (NGS) and bioinformatics data, providing advanced tools for analyzing complex genomic information. The software is designed to deliver medically actionable results across various areas, including oncology, hematological diseases, rare diseases, genetic screening, and hereditary conditions. By addressing the challenges associated with analyzing rich genomic data, SeqOne aims to enhance the accessibility and effectiveness of genomic medicine, thereby facilitating improved treatment options for patients. The company serves both private and public healthcare sectors, contributing to the ongoing transformation of healthcare through the integration of genomic insights.

AlgoTherapeutix is a biotechnology company focused on developing innovative topical treatments for patients suffering from difficult-to-treat conditions, particularly complex pain syndromes. The company targets damaged nerve fibers in the skin to provide localized pain relief while minimizing the systemic side effects often associated with oral medications. AlgoTherapeutix is actively advancing its lead product, ATX01, which has received FDA approval to enter Phase 2 clinical trials for chemotherapy-induced peripheral neuropathy, a painful condition that lacks proven therapeutic options. Additionally, the company is exploring the potential of its treatments for erythromelalgia, a rare and debilitating disorder characterized by severe pain and inflammation. By tailoring therapies to the specific needs of patients, AlgoTherapeutix aims to improve treatment outcomes for individuals facing these challenging health issues.

Corteria Pharmaceuticals is a biotechnology company dedicated to developing innovative therapies for heart failure subpopulations, particularly focusing on acute decompensated heart failure. The company aims to address unmet medical needs by creating first-in-class drugs that enhance the understanding of disease biology among medical professionals. In addition to heart failure, Corteria also explores treatments for related conditions, such as sarcopenia and obesity, to improve patient outcomes and provide effective solutions for complex health issues. Through its research and development efforts, Corteria Pharmaceuticals seeks to transform the landscape of heart failure treatment.

Quandela is a company focused on advancing quantum computing technology, specifically in the realms of communication networks and optical computers. It specializes in manufacturing photonic quantum computers, which it supplies to industrial clients. A key innovation from Quandela is its single-photon source device, which integrates photonics with semiconductor quantum dots. This device enables the efficient collection of emitted single photons at high rates, significantly reducing charge noise decoherence and facilitating the emission of identical photons with high fidelity. Such capabilities are essential for the development of advanced quantum applications in communication, computation, and sensing, positioning Quandela as a pivotal player in the quantum technology landscape.

Coave Therapeutics specializes in developing gene therapies for rare ocular and central nervous system (CNS) diseases. Their primary focus is creating treatments for rare retinal disorders using a recombinant adeno-associated virus vector, which delivers a functional copy of the PDE6B gene directly between photoreceptors and the retinal pigment epithelium to provide effective visual restoration.

Prima Vital provides financing advice and assistance, delivery and installation of safety equipment, after-sales service, and warranty and maintenance of installations. Their customers' inquiries are addressed through phone, email, and online applications.

Ilmatar Energy is a project-oriented integrator specializing in the development, construction, and operation of renewable energy production, particularly through onshore wind farms. The company is committed to significantly contributing to the energy transition in Finland, with a goal of building 1 GW of new wind power capacity over the next five years. Ilmatar engages in long-term Power Purchase Agreements to ensure a stable and sustainable energy supply while actively seeking innovative carbon-neutral energy systems. The company identifies, finances, constructs, and operates renewable energy sites, benefiting from a network of domestic and international partnerships. As part of the Ilmatar Group, Ilmatar Energy is dedicated to expanding its renewable energy portfolio and enhancing energy storage solutions, ultimately aiming to reduce carbon emissions for future generations.

Unseenlabs is a French company founded in 2015 and headquartered in Rennes, Brittany, specializing in marine surveillance services. The company designs and develops advanced spectrum surveillance payloads that enable the detection and tracking of non-cooperative vessels worldwide. Unseenlabs offers comprehensive solutions that encompass satellite design, deployment, and operational support. By launching satellites that can detect and geolocate signals and electromagnetic waves emitted by ships, Unseenlabs provides clients with the capability to monitor maritime activities, even when vessels disable their Automatic Identification System beacons. This technology is particularly valuable for identifying illegal operations such as fishing violations, degassing, and maritime piracy.

PeopleSpheres is a Paris-based company that specializes in providing a comprehensive human resources information system (HRIS) software solution designed to meet the diverse needs of businesses. Founded in 2010 and originally named NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. The software solution offered by PeopleSpheres is tailored to be suitable, sustainable, and scalable, addressing the specific challenges faced by organizations in HR management. To enhance its offerings, PeopleSpheres collaborates with leading national HR service providers, particularly targeting American businesses. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS, further solidifying its position in the HR technology space.

Elistair SAS, founded in 2014 and based in Champagne-au-Mont-d'Or, France, specializes in designing and manufacturing industrial tethered drone systems. The company offers products such as SAFE-T and LIGH-T, which provide real-time persistent observation and aerial capabilities, respectively. These systems enable extended flight times, enhanced safety, and secure high-speed data transfer, making them ideal for various applications, including public safety, private security, traffic monitoring, national security, and law enforcement. Elistair's innovative technology has been deployed in over 30 countries and has garnered several awards, including the 2016 Technology Innovation Award from Frost & Sullivan, establishing the company as a leader in the UAV market.

Artifakt is a developer of cloud application tools that streamline the deployment, management, and operation of web projects within modern cloud infrastructures. The company's platform allows digital teams to configure environments quickly and automate various processes, enabling developers to concentrate on writing, testing, and improving their code. By simplifying cloud deployment, Artifakt empowers teams to work autonomously, significantly enhancing efficiency and accelerating project timelines. This approach not only optimizes the deployment experience but also allows talented developers to focus on their core passion: building innovative web applications.

AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.

Bizay is a technology platform that provides an extensive catalogue of customizable products, operating across Europe, North and South America. The company focuses on digitalizing the product customization industry, allowing local manufacturers, brands, and wholesalers to offer a wide range of customizable items. Bizay targets multiple customer segments, including businesses seeking to sell customized products, small and medium-sized enterprises needing specific product solutions, and major brands leveraging the company's technology for their own customization needs. Its offerings encompass various product categories, such as promotional items, packaging, home and garden goods, fashion and sports products, and beauty and health items. Moreover, Bizay emphasizes sustainability and social responsibility, collaborating with partners that implement inclusion programs and utilizing recycled materials in its products. By optimizing supply chain processes, the company significantly reduces production costs, making customization accessible for a diverse clientele.

AlgoTherapeutix is a biotechnology company focused on developing innovative topical treatments for patients suffering from difficult-to-treat conditions, particularly complex pain syndromes. The company targets damaged nerve fibers in the skin to provide localized pain relief while minimizing the systemic side effects often associated with oral medications. AlgoTherapeutix is actively advancing its lead product, ATX01, which has received FDA approval to enter Phase 2 clinical trials for chemotherapy-induced peripheral neuropathy, a painful condition that lacks proven therapeutic options. Additionally, the company is exploring the potential of its treatments for erythromelalgia, a rare and debilitating disorder characterized by severe pain and inflammation. By tailoring therapies to the specific needs of patients, AlgoTherapeutix aims to improve treatment outcomes for individuals facing these challenging health issues.

Power Capital Renewable Energy Limited, established in 2011 and headquartered in Dublin, Ireland, specializes in developing, operating, and managing large-scale photovoltaic solar farms. The company focuses on acquiring and asset managing utility-scale solar parks, aiming to deliver clean, reliable green electricity. Their expertise spans the entire lifecycle of an asset, from design and development through financing, construction, and operation, ensuring each plant becomes a sustainable and competitive source of renewable energy.

Biosyl SAS is a holding company based in Cosne-Cours-sur-Loire, France, founded in 2010. It specializes in the production of wood energy and fuel wood pellets, utilizing waste and wood scrap to create low-emission energy solutions. Through its subsidiary, Biosyl operates a pellet production plant capable of processing logs into pellets, achieving an annual production capacity exceeding one hundred thousand tons. This innovative approach not only helps in recovering local coppice wood but also enables customers to reduce their carbon footprint by transforming wood waste into energy with minimal CO2 emissions.

Sekoia.io is a developer of an advanced security operations center (SOC) platform that equips security teams with tools to effectively identify and respond to significant cyber threats across their entire attack surface. The platform integrates real-time detection and automation, allowing teams to manage the complexities and high volumes of security incidents while reducing false positives. By continuously analyzing emerging threats and implementing strategic responses, Sekoia.io enables organizations to enhance their security posture and respond to threats more swiftly and reliably than traditional security information and event management (SIEM) systems. This proactive approach ensures that clients remain informed and prepared against evolving cyber risks.

AB Tasty is a software company that specializes in providing a platform for experimentation, personalization, and product optimization aimed at marketing and product teams. Founded in 2009 and headquartered in Paris, France, the company enables businesses across various sectors, including e-commerce, retail, travel, luxury, media, and financial services, to enhance their digital presence. AB Tasty's platform includes tools for A/B testing, multivariate testing, and user engagement, helping organizations convert website and mobile visitors into customers, subscribers, and leads. By leveraging data on online usage, AB Tasty assists teams in creating optimized user experiences that align with their business objectives, ultimately driving increased conversions and revenue across digital channels.

Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

Biofutur is a group of medical biology analysis laboratories based primarily in France. The company operates a network of medical laboratories that provide a wide array of services, including medical consultations, hematology, allergology, immunoassays, and embryo transfer. By focusing on diverse medical analyses and related services, Biofutur aims to meet the healthcare needs of its clients while contributing to advancements in medical biology.

Dust Mobile, established in 2017 and based in Brussels, Belgium, specializes in cybersecurity solutions for mobile networks. The company offers comprehensive protection against threats intrinsic to cellular mobile network signaling (2G, 3G, 4G LTE, and 5G) and SIM cards. Dust Mobile's services include secure voice, text, and data communication solutions, designed to safeguard businesses, critical operations, and connected devices globally.

TISSIUM is a medical device company headquartered in Paris, France, focused on the development and commercialization of innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, provide strong adhesion to tissues, and enable rapid wound closure in the body's dynamic environments. TISSIUM leverages advanced research and intellectual property from renowned laboratories, including those of Robert Langer at MIT and Jeff Karp at Brigham and Women’s Hospital. Its technology platform includes a proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are tailored for tissue reconstruction across various clinical applications. Founded in 2013, TISSIUM is supported by leading healthcare investors and aims to address unmet clinical needs through its groundbreaking approach to wound management.

Solvionic SA is a technology company based in Varilhes, France, that specializes in the development and manufacturing of ionic liquid chemicals for various commercial and industrial applications. Founded in 2003, Solvionic’s products cater to diverse sectors, including pharmaceuticals, petrochemicals, and electrochemistry, among others. The company focuses on sustainable chemistry by employing innovative processes that minimize energy consumption, reduce raw material use, and generate less waste. This approach allows Solvionic to deliver efficient and safe ionic chemicals designed for applications in surface treatment, energy storage, catalysis, extraction, and biotechnology, ensuring cost-effective solutions for its clients.

Biosyl SAS is a holding company based in Cosne-Cours-sur-Loire, France, founded in 2010. It specializes in the production of wood energy and fuel wood pellets, utilizing waste and wood scrap to create low-emission energy solutions. Through its subsidiary, Biosyl operates a pellet production plant capable of processing logs into pellets, achieving an annual production capacity exceeding one hundred thousand tons. This innovative approach not only helps in recovering local coppice wood but also enables customers to reduce their carbon footprint by transforming wood waste into energy with minimal CO2 emissions.

Newronika is a company dedicated to restoring brain and body functions through innovative neuro-modulation technologies. It translates extensive expertise in biosignal decoding into clinical applications aimed at enhancing treatments, health, and overall wellness. By utilizing a therapeutic device that employs a retro-activity system, Newronika records brain activity and modulates neuro-stimulation to analyze and interpret bio-signals. This technology ensures that patients receive the appropriate stimulation at critical moments, enabling them to engage in normal daily activities and improve their quality of life. Founded as a spin-off from two prominent Italian research institutions, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan, Newronika prides itself on a multidisciplinary team of scientists specializing in various fields, including neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.

Wizaplace is a software as a service (SaaS) company based in Lyon, France, that specializes in providing a comprehensive marketplace creation platform. Established in 2012, it offers an all-in-one solution designed to facilitate the development and management of various marketplace models, including B2C, B2B, and C2C projects, as well as services tailored to specific needs. The platform integrates essential functions needed for marketplace operation, featuring a complete back office for administrators and sellers, and an intuitive front office for clients. By enabling customization and providing a user-friendly interface, Wizaplace empowers e-retailers to easily create and manage their online marketplaces within a single cloud-based environment.

Themis Bioscience N.V. is a clinical-stage biopharmaceutical company headquartered in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead product candidate, MV-CHIK, has completed Phase II clinical trials for chikungunya treatment. Themis is also engaged in developing vaccines for various health threats, including cancer, Zika virus, Lassa fever, and MERS. Themis leverages its advanced understanding of immune system mechanisms through its innovative vaccine platform, focusing on both emerging and specialized indications. The company has established research collaborations and exclusive licensing agreements to enhance its development capabilities, positioning itself as a strategic partner for leading biotechnology and pharmaceutical firms.

Spherea is a French company that manufactures and supplies testing solutions for electrical applications across various industries. Their product range includes model-based testing tools, field test equipment, wiring testers, and maintenance support systems. These solutions cater to manufacturers, suppliers, integrators, and operators within the aerospace, defense, energy, and rail sectors both domestically and internationally.

Bankin' is a mobile application focused on simplifying money management for its users. With a user base of over 1.5 million across France, England, Spain, and Germany, the company prides itself on being the leading independent money management solution in Europe. The app utilizes intelligent algorithms and human coaching to deliver personalized advice related to savings, credit, and insurance, ensuring that customers can manage their finances efficiently. Bankin' emphasizes its commitment to transparency and simplicity, allowing users to concentrate on their priorities without the complications often associated with financial management. By remaining independent of traditional banking institutions, Bankin' aims to provide unbiased guidance tailored to the individual needs of its customers.

NH TherAguix SAS is a clinical-stage pharmaceutical company based in Villeurbanne, France, focused on the development of nanomedicines for cancer treatment. The company specializes in creating innovative therapeutics that enhance radiotherapy for solid tumors. Its lead product, AGuIX, is a theranostic nanoparticle designed to improve the localization of tumors and optimize radiation therapy outcomes. By facilitating intravenous administration, AGuIX enables healthcare professionals to determine the best timing for irradiation, targets tumor tissues more effectively, and minimizes adverse effects on healthy tissues by reducing radiation doses. Founded in 2015, NH TherAguix is dedicated to advancing cancer treatment through its pioneering approach to combining imaging and radiotherapy.

AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.

Therapixel SA is a company based in Valbonne, France, with additional locations across multiple countries, including Australia and China. Founded in 2013, Therapixel specializes in designing and developing medical image analytics software for surgeons, leveraging artificial intelligence to enhance surgical procedures. Their product portfolio includes Radvise, an automatic image reading solution; Fluid, a touchless medical image navigation system for surgery; Anywhere, a post-processing workstation; and CD-Feed, a solution for importing CDs from outpatient imaging exams. The company also focuses on AI-based software for breast cancer detection and characterization, providing healthcare professionals with pertinent information to support decision-making during surgeries while adhering to sterility constraints.

Teach on Mars SAS is a leading provider of mobile learning technology based in Sophia Antipolis, France, with additional offices in Paris, Milan, and London. Founded in 2013, the company has established itself as a prominent player in the mobile learning sector, delivering solutions to over 100 clients in more than 60 countries and in 20+ languages. The platform enables organizations to create mobile courses and learning games, manage training programs, and analyze learner progress through comprehensive analytics. Teach on Mars offers various applications, including Learn on Mars for personalized learning experiences and Quiz on Mars, which promotes engagement through social learning games. Additionally, the company provides training, certification, and support services, as well as integration and professional content marketplace solutions. With a dedicated team and a global network of partners, Teach on Mars aims to equip organizations with the necessary tools and expertise to develop effective learning ecosystems while committing 1% of its revenues to education initiatives aligned with the UN Sustainable Development Goals.

Bizay is a technology platform that provides an extensive catalogue of customizable products, operating across Europe, North and South America. The company focuses on digitalizing the product customization industry, allowing local manufacturers, brands, and wholesalers to offer a wide range of customizable items. Bizay targets multiple customer segments, including businesses seeking to sell customized products, small and medium-sized enterprises needing specific product solutions, and major brands leveraging the company's technology for their own customization needs. Its offerings encompass various product categories, such as promotional items, packaging, home and garden goods, fashion and sports products, and beauty and health items. Moreover, Bizay emphasizes sustainability and social responsibility, collaborating with partners that implement inclusion programs and utilizing recycled materials in its products. By optimizing supply chain processes, the company significantly reduces production costs, making customization accessible for a diverse clientele.

ABMI is an engineering company specializing in various technological domains. The firm provides comprehensive solutions in areas such as design, IT infrastructure, robotics, the Internet of Things (IoT), cloud computing, and cybersecurity. ABMI operates within a rapidly expanding market, leveraging its expertise across multiple disciplines to deliver innovative and effective technical services.

Captain Tortue is the European leader in direct selling women's ready-to-wear clothing. Every year, it designs around 330 models through its four brands: Trend (trendy collection, urban chic), Miss (classic and casual collection), Little Miss (children's collections, teenagers and small sizes) and Java (home wear comfort-casual).

Sentryo SAS is a cybersecurity company that specializes in providing solutions for industrial networks and the Internet of Things. Founded in 2014 and headquartered in Charbonnières-les-Bains, France, Sentryo focuses on ensuring the resilience and safety of industrial operations by offering continuous visibility over Industrial Control Systems (ICS) and SCADA infrastructures. The company's flagship product, ICS CyberVision, enables control engineers to monitor all equipment connected to industrial networks, identify vulnerabilities, and make informed decisions to maintain system integrity. Sentryo's solutions leverage artificial intelligence and machine learning algorithms to deliver real-time insights, detect anomalies, and manage cyber risks effectively. The company serves various sectors, including smart cities, utilities, and energy grids, making it a crucial player in securing critical infrastructures. As of 2019, Sentryo operates as a subsidiary of Cisco Systems, Inc.

Intersec SA, established in 2004, is a global technology company headquartered in Paris, France, with an additional office in London, UK. It specializes in providing streaming analytics solutions to various sectors, including telecommunications, utilities, manufacturing, financial services, and retail. Intersec's offerings encompass customer base management, location data monetization, fraud management, public safety, IoT analytics, and messaging solutions. The company's solutions enable organizations to derive real-time insights from vast amounts of data, helping them to optimize operations, enhance customer experiences, and drive new revenue streams. Intersec serves over 90 clients across 40 countries, reaching nearly one billion connected devices and covering over 400 million people with its mission-critical communication solutions. Recognized by Gartner as a leading vendor in location intelligence and telecom data monetization, Intersec prioritizes privacy and regulatory compliance, ensuring it operates responsibly worldwide.

GEEV is a collaborative mobile application that facilitates the donation and collection of various items among its users, promoting a culture of sharing and reducing waste. The platform allows individuals to donate objects they no longer need and to retrieve free items from others in their community. By providing features for communication and coordination, GEEV fosters interaction between users, enabling them to discuss and arrange meetups for the exchange of goods. The app not only helps users declutter but also encourages sustainable practices by giving objects a second life, thereby contributing to waste reduction efforts.

Antabio is a private biopharmaceutical company based in Labege, France, focused on developing innovative treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating novel antibacterial resistance-breakers, including stand-alone inhibitors of bacterial metalloenzymes. These inhibitors are designed to be combined with existing antibiotics, such as carbapenems, to restore their efficacy against the most challenging pathogens responsible for life-threatening infections, including carbapenem-resistant nosocomial pneumonia. Antabio aims to address significant unmet medical needs in the treatment of drug-resistant infections, ultimately providing healthcare professionals with effective medicinal products to combat these critical health challenges. The company has been recognized for its work, receiving a Wellcome Trust Seeding Drug Discovery Award.

Marquetis & Co, founded in 1996 and based in Boulogne Billancourt, France, operates within the French marketing and communications sector. The company provides a comprehensive range of operational marketing services through its subsidiaries, including Marquetis One, Marquetis Connect, and Marquetis Call. Marquetis specializes in relational branding strategies, offering clients services in strategic consulting, creative development, digital marketing, and customer engagement. The firm focuses on delivering automated cross-channel marketing solutions in a Software as a Service (SaaS) format, employing predictive performance models to enhance brand strategies and ensure effective communication. Managed by Virginie Massa and Evangelos Vatzias, Marquetis has established itself as a key player in the marketing landscape, delivering tailored solutions that meet the diverse needs of enterprises.

Tiller Systems SAS is a Paris-based company that specializes in developing cloud-based point of sale (POS) software solutions for restaurants and merchants. Founded in March 2014, Tiller's management tools enable users to accept various payment types, integrate partner applications, and effectively oversee staff and inventory in real time. The software features a mobile POS system that allows for the management of both in-store and online orders from a single platform. Additionally, Tiller offers a web dashboard that facilitates catalog updates, sales tracking, employee payments, stock alerts, customer relationship management, and access to real-time reporting and performance metrics. With additional offices in Barcelona and Milan, Tiller Systems aims to empower businesses to make informed decisions and enhance their operational efficiency.

The Mistral group markets an integrated software solution (ERP) dedicated to the market and the business of dealers, renters, resellers of agricultural equipment and construction equipment. The group consists of two entities, Mistral Informatique (publisher of software and mobility applications) and Mistral DataCenter (hosting and outsourcing services).

S.A. Nanomakers is a Paris-based company established in 2010 that focuses on the design, manufacturing, and marketing of silicon-based nanomaterials, particularly nanopowders. These patented, nano-scale powders serve to significantly enhance the mechanical, thermal, and chemical properties of various industrial materials, including metal alloys and elastomers. Nanomakers' silicon carbide and silicon nanopowders play a crucial role in advancing sectors such as semiconductors, energy storage, aerospace, and automotive. The company's innovative materials double the energy storage density of lithium-ion batteries by utilizing nano-composites, thereby positioning Nanomakers at the forefront of technology that drives performance improvements across multiple industries.

Tilkee is a cloud-based application that enhances the efficiency of sales teams by tracking business proposals and optimizing prospect follow-up. The platform allows users to upload sales documents, create customized online proposals, and generate unique links for their prospects. It provides real-time notifications on document engagement, revealing who has viewed the proposals, the focus of their attention, and the duration of their engagement. This data-driven approach enables sales professionals to assess prospects' interest and readiness to close deals, ultimately improving their sales performance and marketing effectiveness.

Scality, Inc. is a leading provider of software-defined storage solutions, specializing in active archives, content distribution, and cloud services. Founded in 2009 and headquartered in San Francisco, with an additional office in Cambridge, Massachusetts, the company developed RING, a scalable software-based storage system capable of managing petabytes of data. RING supports high-performance, parallel processing, and integrates seamlessly with various applications through standard storage protocols such as NFS and S3. This innovative storage architecture delivers billions of files to hundreds of millions of users daily, ensuring 100% availability and reducing operational costs. Scality serves a diverse range of clients, including major media and telecommunications companies, as well as leading firms across the U.S., Europe, and Japan. The company is recognized for its ability to help enterprises and service providers effectively address the challenges of large-scale data storage.

ForCity is a software-as-a-service (SaaS) company that specializes in developing a decision support platform focused on urban planning and management. Utilizing advanced 3D and 4D simulation technology, ForCity's platform integrates various datasets pertaining to urban parameters such as energy consumption, water usage, real estate projects, and land availability. This comprehensive approach enables municipalities to generate detailed reports that aid in strategic planning and operational optimization. By providing valuable insights, ForCity empowers local governments to enhance their development strategies in areas such as energy management, waste reduction, land use, and economic development, ultimately contributing to the creation of smarter, more sustainable cities.

VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for semiconductor chips used in advanced digital communications systems, including 5G networks. Founded in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the need for DSP co-processors, allowing for greater flexibility akin to software programming. VSORA's innovative DSP development flow facilitates collaboration between signal processing and software engineers, significantly accelerating time-to-market for new products. The company focuses on enhancing DSP computing power while optimizing power consumption and performance, ultimately reducing the silicon footprint required for complex integrated circuits.

Pherecydes Pharma SA is a biotechnology company based in Romainville, France, that specializes in the research and development of lytic bacteriophages for therapeutic and diagnostic purposes, particularly in the context of antibiotic resistance. Established in 2006, the company is dedicated to creating personalized phage therapies aimed at treating bacterial infections. It has developed several banks of bacteriophages, including those targeting Escherichia coli, and has initiated multicenter clinical trials across Europe to assess the efficacy of phage therapy in treating infected burn wounds. By harnessing the natural ability of bacteriophages to infect and eliminate bacteria without affecting human cells, Pherecydes Pharma aims to provide innovative solutions for combating a wide range of bacterial threats, including multi-resistant and emergent strains.

Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

Themis Bioscience N.V. is a clinical-stage biopharmaceutical company headquartered in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead product candidate, MV-CHIK, has completed Phase II clinical trials for chikungunya treatment. Themis is also engaged in developing vaccines for various health threats, including cancer, Zika virus, Lassa fever, and MERS. Themis leverages its advanced understanding of immune system mechanisms through its innovative vaccine platform, focusing on both emerging and specialized indications. The company has established research collaborations and exclusive licensing agreements to enhance its development capabilities, positioning itself as a strategic partner for leading biotechnology and pharmaceutical firms.

Coave Therapeutics specializes in developing gene therapies for rare ocular and central nervous system (CNS) diseases. Their primary focus is creating treatments for rare retinal disorders using a recombinant adeno-associated virus vector, which delivers a functional copy of the PDE6B gene directly between photoreceptors and the retinal pigment epithelium to provide effective visual restoration.

Aero Negoce International, SAS, established in 1993 and headquartered in Béziers, France, specializes in manufacturing and distributing fasteners and hardware tailored for the aerospace industry. The company offers a diverse range of products, including fasteners, spherical plain bearings, connectors, lamps, seals, and hinges. In addition to its manufacturing capabilities, Aero Negoce International provides contract management, consignment stock, and custom packing services to meet the needs of its clients. Its primary customers include prominent aircraft manufacturers such as Airbus and Dassault, along with key suppliers like Zodiac and Safran, positioning the company as a vital player in the aerospace supply chain.

Groupe InCa SAS, founded in 1954 and headquartered in Artigues Près Bordeaux, France, is a prominent player in the construction industry within the New Aquitaine region. The company specializes in the building of custom-designed detached homes, catering to a diverse clientele that includes both first-time buyers and high-end customers. It operates under three well-established brands: Maisons Clairlande, Les Demeures de la Côte d’Argent, and Rouquié Constructions. Through its focus on quality and tailored solutions, Groupe InCa has positioned itself as a regional leader in the residential construction market.

Groupe InCa SAS, founded in 1954 and headquartered in Artigues Près Bordeaux, France, is a prominent player in the construction industry within the New Aquitaine region. The company specializes in the building of custom-designed detached homes, catering to a diverse clientele that includes both first-time buyers and high-end customers. It operates under three well-established brands: Maisons Clairlande, Les Demeures de la Côte d’Argent, and Rouquié Constructions. Through its focus on quality and tailored solutions, Groupe InCa has positioned itself as a regional leader in the residential construction market.

AB Tasty is a software company that specializes in providing a platform for experimentation, personalization, and product optimization aimed at marketing and product teams. Founded in 2009 and headquartered in Paris, France, the company enables businesses across various sectors, including e-commerce, retail, travel, luxury, media, and financial services, to enhance their digital presence. AB Tasty's platform includes tools for A/B testing, multivariate testing, and user engagement, helping organizations convert website and mobile visitors into customers, subscribers, and leads. By leveraging data on online usage, AB Tasty assists teams in creating optimized user experiences that align with their business objectives, ultimately driving increased conversions and revenue across digital channels.

Batiweb.com is a B2B web portal dedicated to the housing and construction sectors, positioning itself as a key player in the market. The platform serves as a digital networking hub that connects trade professionals with consumers, offering essential information on construction, renovation, and housing-related issues. Batiweb operates through three main activities: intermediation, media, and various services, which collectively address the needs of clients in the construction industry. By continuously expanding its product offerings, Batiweb aims to establish itself as the leading online group focused on construction, housing, and decoration.

RGF Group is a manufacturer specializing in plastic injection molding, catering to various sectors such as healthcare, sports, construction, home automation, automotive, and industrial equipment. The company utilizes advanced technology, including electric and hydraulic machines, to offer both single and bi-material injection solutions. In addition to manufacturing, RGF Group provides expertise in the design and production of injection tooling, ensuring high-quality and efficient service. With production facilities located in France and globally, RGF Group emphasizes flexibility and responsiveness to meet the industrial challenges of its clients.

MultiX S.A., founded in 2010 and headquartered in Neuilly-sur-Seine, France, specializes in designing, producing, and selling spectrometric X-ray detectors. These detectors are used for material identification in various applications including security, food processing, mining, recycling, industry, and non-destructive testing. MultiX's advanced multi-energy technology is particularly beneficial for reducing false alarms in baggage screening systems at airports and sensitive infrastructure, thereby enhancing passenger facilitation and experience by minimizing the need to remove liquids and laptops from hand baggage while adhering to stringent security regulations. The company supplies system manufacturers with this technology, enabling them to improve operational efficiency and meet regulatory standards across multiple industries.

Circet, a leading French company, specializes in constructing, maintaining, and repairing fixed and mobile telecommunication networks for major operators and large user accounts. It is renowned for its agile and flexible turnkey solutions, focusing on process industrialization and efficient management of these services.

OCTIMET Oncology NV is a biotechnology company based in Beerse, Belgium, that specializes in developing MET kinase inhibitors for cancer treatment. Founded in 2016, the company focuses on advancing discovery-stage molecules, including cMET inhibitors and other selective anti-tumor agents. OCTIMET employs innovative strategies for patient selection and pharmacodynamic biomarkers to enhance the clinical development of its therapies. By utilizing biomarker-defined intelligent patient selection, OCTIMET aims to provide differentiated treatment options for patients with solid tumors, thereby improving outcomes within existing treatment paradigms.

Bankin' is a mobile application focused on simplifying money management for its users. With a user base of over 1.5 million across France, England, Spain, and Germany, the company prides itself on being the leading independent money management solution in Europe. The app utilizes intelligent algorithms and human coaching to deliver personalized advice related to savings, credit, and insurance, ensuring that customers can manage their finances efficiently. Bankin' emphasizes its commitment to transparency and simplicity, allowing users to concentrate on their priorities without the complications often associated with financial management. By remaining independent of traditional banking institutions, Bankin' aims to provide unbiased guidance tailored to the individual needs of its customers.

Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

Themis Bioscience N.V. is a clinical-stage biopharmaceutical company headquartered in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead product candidate, MV-CHIK, has completed Phase II clinical trials for chikungunya treatment. Themis is also engaged in developing vaccines for various health threats, including cancer, Zika virus, Lassa fever, and MERS. Themis leverages its advanced understanding of immune system mechanisms through its innovative vaccine platform, focusing on both emerging and specialized indications. The company has established research collaborations and exclusive licensing agreements to enhance its development capabilities, positioning itself as a strategic partner for leading biotechnology and pharmaceutical firms.

Ducatillon is a retailer specializing in the distribution of breeding equipment for pets, poultry, and small livestock such as rabbits and goats, catering primarily to amateur enthusiasts and families. Additionally, the company offers hunting equipment and accessories tailored to recreational hunters and their dogs. Ducatillon's product range aims to provide customers with branded, durable goods suitable for hobby farming and outdoor leisure activities.

Oxatis SA is a provider of e-commerce technology solutions based in Marseille, France, established in 2001. The company specializes in offering Software as a Service (SaaS) tools designed for small businesses to create comprehensive websites and establish an online presence. Its offerings include online content management system (CMS) software, hosting services, and integrated shopping cart solutions. These tools enable users to sell products online with minimal technical expertise and investment, making e-commerce accessible to a broader range of entrepreneurs.

Bizay is a technology platform that provides an extensive catalogue of customizable products, operating across Europe, North and South America. The company focuses on digitalizing the product customization industry, allowing local manufacturers, brands, and wholesalers to offer a wide range of customizable items. Bizay targets multiple customer segments, including businesses seeking to sell customized products, small and medium-sized enterprises needing specific product solutions, and major brands leveraging the company's technology for their own customization needs. Its offerings encompass various product categories, such as promotional items, packaging, home and garden goods, fashion and sports products, and beauty and health items. Moreover, Bizay emphasizes sustainability and social responsibility, collaborating with partners that implement inclusion programs and utilizing recycled materials in its products. By optimizing supply chain processes, the company significantly reduces production costs, making customization accessible for a diverse clientele.